Company Profile
Organogenesis Stock Price, News & Analysis
- Ticker:
- ORGO
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
2.41 USD (+1.69%)
Close
Last updated: August 6, 2026
288M USD
Market cap
Why the stock is moving
The latest monitored company update is “Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results.” The corresponding closing-price reaction is not yet available.
Company overview
Regenerative Medicine
Organogenesis develops and manufactures regenerative-medicine products used to support healing in difficult wounds and surgical procedures.
Advanced Wound Care
The company's wound-care portfolio includes cellular and tissue-based products, placental-derived products and other biologic matrices used in chronic and complex wounds.
Surgical and Sports Medicine
Organogenesis also supplies products for orthopedic, sports-medicine and surgical applications, where its biologic materials are used to support soft-tissue repair and healing.
Future catalysts
Organogenesis’s catalysts are PuraPly, Affinity, and the broader wound-care and surgical portfolio. The business moves on adoption, reimbursement, and product-mix execution.
Recent news
- 01
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results
Source: Organogenesis
- 02
- 03
- 04
- 05
Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results
Source: Organogenesis
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Organogenesis (ORGO)?
Organogenesis (ORGO) most recently closed at 2.41 USD, a +1.69% move versus the previous session.
What is the market cap of Organogenesis (ORGO)?
Organogenesis currently has a market capitalization of 288M USD on BioPharmSignal.
What does Organogenesis do?
Regenerative Medicine Organogenesis develops and manufactures regenerative-medicine products used to support healing in difficult wounds and surgical procedures. Advanced Wound Care The company's wound-care portfolio includes cellular and tissue-based products, placental-derived products and other biologic matrices used in chronic and complex...
On which exchange is ORGO stock listed?
Organogenesis (ORGO) is associated with NASDAQ, United States, Biopharma.
What is Regenerative?
Regenerative Medicine Organogenesis develops and manufactures regenerative-medicine products used to support healing in difficult wounds and surgical procedures.
Which conditions is Organogenesis targeting with Regenerative?
Regenerative Medicine Organogenesis develops and manufactures regenerative-medicine products used to support healing in difficult wounds and surgical procedures. Advanced Wound Care The company's wound-care portfolio includes cellular and tissue-based products, placental-derived products and other biologic matrices used in chronic and complex...
How does Organogenesis describe recent progress with Regenerative?
Organogenesis’s catalysts are PuraPly, Affinity, and the broader wound-care and surgical portfolio. The business moves on adoption, reimbursement, and product-mix execution.
What is Medicine?
Regenerative Medicine Organogenesis develops and manufactures regenerative-medicine products used to support healing in difficult wounds and surgical procedures.